Motley Fool News Releases and Press Releases From 07/13/24

2024-07-13 10:53:00 ET The stock market enjoyed a strong first half, with the S&P 500 rallying 14.5%. Given the election uncertainty and growing macroeconomic concerns, it will be hard for the market to repeat that performance in the second half. Many dividend stocks enjoyed...

2024-07-13 10:53:00 ET The stock market enjoyed a strong first half, with the S&P 500 rallying 14.5%. Given the election uncertainty and growing macroeconomic concerns, it will be hard for the market to repeat that performance in the second half. Many dividend stocks enjoyed...

2024-07-13 10:53:00 ET The stock market enjoyed a strong first half, with the S&P 500 rallying 14.5%. Given the election uncertainty and growing macroeconomic concerns, it will be hard for the market to repeat that performance in the second half. Many dividend stocks enjoyed...

2024-07-13 10:43:00 ET Megan Gorman is the author of All the Presidents' Money: How the Men Who Governed America Governed Their Money . Gorman is also the founding partner of Chequers Financial Management. In this podcast, Motley Fool personal finance expert Robert Brokamp caught up...

2024-07-13 09:45:00 ET Roku (NASDAQ: ROKU) has made balancing multiple streaming services much easier over the years. Simply plug one of its streaming sticks into your TV, and you can quickly access content from a wide range of streaming services. Its Roku channel also provides user...

2024-07-13 09:36:30 ET Fool.com contributor Parkev Tatevosian discusses what this could mean for Tesla (NASDAQ: TSLA) stock investors. *Stock prices used were the afternoon prices of July 10, 2024. The video was published on July 12, 2024. Continue reading Fo...

2024-07-13 09:31:35 ET Fool.com contributor Parkev Tatevosian previews a major investor update from ASML (NASDAQ: ASML) . *Stock prices used were the afternoon prices of July 10, 2024. The video was published on July 12, 2024. Continue reading For further det...

2024-07-13 09:29:00 ET Recursion Pharmaceuticals (NASDAQ: RXRX) is arguably one of the most unique drugmakers on the planet. Though it's classified as a biotech company, its claim to fame is an artificial intelligence (AI)-based approach to speeding up drug discovery and development...

2024-07-13 09:25:44 ET Fool.com contributor Parkev Tatevosian compares Microsoft (NASDAQ: MSFT) and Amazon (NASDAQ: AMZN) to determine the better investment. *Stock prices used were the afternoon prices of July 10, 2024. The video was published on July 12, 2024. ...

2024-07-13 09:25:44 ET Fool.com contributor Parkev Tatevosian compares Microsoft (NASDAQ: MSFT) and Amazon (NASDAQ: AMZN) to determine the better investment. *Stock prices used were the afternoon prices of July 10, 2024. The video was published on July 12, 2024. ...